Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Search Results

Your search returned 1870 record(s).

Page 148 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:

  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1471 7.7 months Newly diagnosed GBM 4 Chemotherapy
McGill University Canada 5/2002
Treatment Details: Patients: This study involved 12 patients with newly diagnosed glioblastoma multiforme. Treatment: Treatment consisted of surgery followed by the administration of the chemotherapy drug
1472 7.7 months Androgen-independent prostate cancer Chemotherapy
St Bartholomew's Hospital United Kingdom 1/2008
Treatment Details: Patients: This phase II study involved 43 men with androgen-independent prostate cancer. They ranged in age from 50 to 86 years old. The median age was 72. Treatment: After undergoi
1473 7.7 months Metastatic cutaneous melanoma 5 Chemotherapy
Churchill Hospital United Kingdom 6/2007
Treatment Details: Patients: This phase III study involved one hundred and four patients with cutaneous melanoma or unknown primary melanoma with metastases. They were randomly divided into two groups of 52
1474 7.7 months NSCLC 4 Chemotherapy
Hellenic Oncology Research Group Greece 11/2010
Treatment Details: Patients: Non-small cell lung cancer patients in this phase 3 study were divided into two treatment groups. Group 1 consisted of 67 patients with a median age of 62 years, 95.5% of whom we
1475 7.7 months Triple-negative Metastatic breast cancer 5 Chemotherapy
Baylor Charles A. Sammons Cancer Center United States 1/2011
Treatment Details: Patients: This study involved women with triple-negative metastatic breast cancer, which is type of cancer that does not have estrogen receptor (ER-), progesterone receptor (PR-), or an abu
1476 7.7 months Advanced colorectal cancer 4 Biologic therapy
Campus Bio-Medico University Italy 10/2010
Treatment Details: Patients: This study involved 48 patients with advanced colorectal cancer whose cancer had progressed following previous standard chemotherapy approaches. The median patient age was 68 (ra
1477 7.7 months NSCLC 4 Biologic therapy
Istituto di Ricovero e Cura a Carattere Scientifico Italy 6/2014
Treatment Details: Patients: This phase 3 study involved 134 non-small cell lung cancer patients who had progressed following, or were deemed refractory to, platinum-based chemotherapy. The median patient ag
1478 7.6 months Advanced hepatocellular carcinoma 4 Biologic therapy
The Miriam Hospital United States 7/2013
Treatment Details: Patients: This phase 2 study involved 40 advanced hepatocellular cancer patients who had been previously treated with sorafenib. The median patient age was 60.5 years and 34 were male.
1479 7.6 months Advanced hepatocellular carcinoma 4 Chemotherapy
National Cancer Center Hospital Japan 8/2013
Treatment Details: Patients: This phase 2 study involved 25 advanced hepatocellular carcinoma patients who had portal vein tumor thrombosis (PVTT). The median patient age was 67 years and 20 were male. Tr
1480 7.6 months Anaplastic glioma 5 Biologic therapy
National Cancer Institute United States 12/2012
Treatment Details: Patients: Patients in this phase 2 study were divided into 2 groups based on their particular form of brain cancer. Group A consisted of 32 glioblastoma multiforme patients with a median a
Page 148 of 187  | Previous Page  | Next Page